BioImage A/S Company Profile

01:05 EST 20th November 2017 | BioPortfolio

BioImage A/S uses its expertise in redistributionâ„¢ technologies to discover drug candidates that change the activity of specific signaling pathways without inhibiting the catalytic activity of signaling proteins. Increased or decreased activity of a pathway is achieved by targeting the exquisitely specific interactions by which signaling proteins control cellular information flow. BioImage specialises in discovering leads against known signaling targets that cannot be inhibited with absolute specificity by traditional means. The Company's high-throughput cell-based redistribution assays make these targets amenable to drug discovery.

BioImage's technologies enable the discovery of drugs that precisely target individual signaling proteins. Drugs with this new mode of action will demonstrate completely different selectivity profiles compared to traditional active-site inhibitors, and are likely to produce fewer side effects. The Company's novel approach offers exceptional target and drug discovery opportunities in most therapeutic areas. BioImage is currently focused on inflammatory and autoimmune diseases, diabetes, cancers and cardiovascular diseases.

BioImage has developed proprietary cell-based imaging technologies that allow protein interactions and translocations to be visualized in living cells in real time using high-throughput, automated redistribution assays. BioImage is the first company to discover new drug targets and drug candidates in this way. The Company will co-develop the output of its discovery efforts with pharmaceutical partners to produce novel therapeutics.


Moerkhoej Bygade 28


Phone: +45 44 43 34 44
Fax: +45 44 43 75 05

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

DiversePathsJ: Diverse Shortest Paths for Bioimage Analysis.

We introduce a formulation for the general task of finding diverse shortest paths between two end-points. Our approach is not linked to a specific biological problem and can be applied to a large vari...

A novel benzothiazole-based fluorescent probe for cysteine detection and its application on test paper and in living cells.

A novel simple and readily synthesized turn-on fluorescent probe 4-(benzo[d]thiazol-2-yl)-1,3-phenylene bis(2-chloroacetate) (BPBC) for cysteine (Cys) was reported. This probe was designed based on an...

A Two-Distinctly-Separated-Emission Colorimetric NIR Fluorescent Probe for Fast Hydrazine Detection in Living Cells and Mice upon Independent Excitations.

Hydrazine is carcinogenic and highly toxic so that it can lead to serious environmental contamination and serious health risks although it has been extensively used as an effective propellant and an i...

An Organelle Correlation-Guided Feature Selection Approach for Classifying Multi-Label Subcellular Bio-images.

Nowadays, with the advances in microscopic imaging, accurate classification of bioimage-based protein subcellular location pattern has attracted as much attention as ever. One of the basic challenging...

Image analysis of neural stem cell division patterns in the zebrafish brain.

Proliferating stem cells in the adult body are the source of constant regeneration. In the brain, neural stem cells (NSCs) divide to maintain the stem cell population and generate neural progenitor ce...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Natural History of Carotid Plaque as Determined by 3D Ultrasound

This proposed follow-up study aims to recruit participants from the original BioImage cohort for a one-time follow-up examination. The repeat ultrasound scan of the carotid arteries will p...

BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

The BioImage Study is a study of the characteristics of subclinical cardiovascular disease, as measured by imaging modalities, unsupervised circulating biomarker measurements, and risk fac...

BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study

Obstructive lung disease is an increasing global health problem of pandemic proportions, with COPD alone affecting >10% of the population. Smoking is the main and most well studies risk fa...

Companies [2 Associated Companies listed on BioPortfolio]

BioImage A/S

BioImage A/S uses its expertise in redistributionâ„¢ technologies to discover drug candidates that change the activity of specific signaling pathways without inhibiting the catalytic activity of s...

Fisher BioImage ApS

BioImage is a life science company that has pioneered the field of High Content Pathway Analysis. We provide products, services, and broadly-enabling licenses to the life science market that are based...

More Information about "BioImage A/S" on BioPortfolio

We have published hundreds of BioImage A/S news stories on BioPortfolio along with dozens of BioImage A/S Clinical Trials and PubMed Articles about BioImage A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioImage A/S Companies in our database. You can also find out about relevant BioImage A/S Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record